Table of Contents
ISRN Obesity
Volume 2012, Article ID 490870, 6 pages
http://dx.doi.org/10.5402/2012/490870
Research Article

Aqueous Extract from Pepino (Solanum muricatum Ait.) Attenuated Hyperlipidemia and Cardiac Oxidative Stress in Diabetic Mice

1School of Nutrition, Chung Shan Medical University, Taichung 404, Taiwan
2Department of Nutrition, Chung Shan Medical University Hospital, Taichung 404, Taiwan
3Department of Nutrition, China Medical University, Taichung 404, Taiwan

Received 18 March 2012; Accepted 30 April 2012

Academic Editors: D. Fernandez-Twinn, B. Navia, and D. Ofir

Copyright © 2012 Zhi-hong Wang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. Brownlee, “Biochemistry and molecular cell biology of diabetic complications,” Nature, vol. 414, no. 6865, pp. 813–820, 2001. View at Publisher · View at Google Scholar · View at Scopus
  2. C. Weyer, C. Bogardus, D. M. Mott, and R. E. Pratley, “The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus,” Journal of Clinical Investigation, vol. 104, no. 6, pp. 787–794, 1999. View at Google Scholar · View at Scopus
  3. R. B. Goldberg, “Cardiovascular disease in patients who have diabetes,” Cardiology Clinics, vol. 21, pp. 399–413, 2003. View at Google Scholar
  4. C. A. Reasner, “Reducing cardiovascular complications of type 2 diabetes by targeting multiple risk factors,” Journal of Cardiovascular Pharmacology, vol. 52, no. 2, pp. 136–144, 2008. View at Publisher · View at Google Scholar · View at Scopus
  5. P. Newsholme, E. P. Haber, S. M. Hirabara et al., “Diabetes associated cell stress and dysfunction: role of mitochondrial and non-mitochondrial ROS production and activity,” Journal of Physiology, vol. 583, no. 1, pp. 9–24, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. S. I. Gorogawa, Y. Kajimoto, Y. Umayahara et al., “Probucol preserves pancreatic β-cell function through reduction of oxidative stress in type 2 diabetes,” Diabetes Research and Clinical Practice, vol. 57, no. 1, pp. 1–10, 2002. View at Publisher · View at Google Scholar · View at Scopus
  7. W. Ren and D. G. Tang, “Extract of Solanum muricatum (Pepino/CSG) inhibits tumor growth by inducing apoptosis,” Anticancer Research, vol. 19, no. 1, pp. 403–408, 1999. View at Google Scholar · View at Scopus
  8. C. C. Hsu, Y. R. Guo, Z. H. Wang, and M. C. Yin, “Protective effects of an aqueous extract from pepino (Solanum muricatum Ait.) in diabetic mice,” Journal of the Science of Food and Agriculture, vol. 91, no. 8, pp. 1517–1522, 2011. View at Publisher · View at Google Scholar · View at Scopus
  9. C. M. Kusminski, P. G. McTernan, and S. Kumar, “Role of resistin in obesity, insulin resistance and Type II diabetes,” Clinical Science, vol. 109, no. 3, pp. 243–256, 2005. View at Publisher · View at Google Scholar · View at Scopus
  10. P. G. McTernan, C. L. McTernan, R. Chetty et al., “Increased resistin gene and protein expression in human abdominal adipose tissue,” Journal of Clinical Endocrinology and Metabolism, vol. 87, no. 5, pp. 2407–2410, 2002. View at Publisher · View at Google Scholar · View at Scopus
  11. C. L. E. Yen, S. J. Stone, S. Koliwad, C. Harris, and R. V. Farese Jr., “DGAT enzymes and triacylglycerol biosynthesis,” Journal of Lipid Research, vol. 49, no. 11, pp. 2283–2301, 2008. View at Publisher · View at Google Scholar · View at Scopus
  12. J. Kusunoki, A. Kanatani, and D. E. Moller, “Modulation of fatty acid metabolism as a potential approach to the treatment of obesity and the metabolic syndrome,” Endocrine, vol. 29, no. 1, pp. 91–100, 2006. View at Publisher · View at Google Scholar · View at Scopus
  13. K. Srinivasan, B. Viswanad, L. Asrat, C. L. Kaul, and P. Ramarao, “Combination of high-fat diet-fed and low-dose streptozotocin-treated rat: a model for type 2 diabetes and pharmacological screening,” Pharmacological Research, vol. 52, no. 4, pp. 313–320, 2005. View at Publisher · View at Google Scholar · View at Scopus
  14. O. H. Lowry, N. J. Rosebrough, A. L. Farr, and R. J. Randall, “Protein measurement with the Folin phenol reagent,” Journal of Biological Chemistry, vol. 193, no. 1, pp. 265–275, 1951. View at Google Scholar · View at Scopus
  15. E. G. Bligh and W. J. Dyer, “A rapid method of total lipid extraction and purification,” Canadian Journal of Biochemistry and Physiology, vol. 37, no. 8, pp. 911–917, 1959. View at Google Scholar · View at Scopus
  16. R. Gupta, D. K. Dubey, G. M. Kannan, and S. J. S. Flora, “Concomitant administration of Moringa oleifera seed powder in the remediation of arsenic-induced oxidative stress in mouse,” Cell Biology International, vol. 31, no. 1, pp. 44–56, 2007. View at Publisher · View at Google Scholar · View at Scopus
  17. J. P. Bastard, M. Maachi, C. Lagathu et al., “Recent advances in the relationship between obesity, inflammation, and insulin resistance,” European Cytokine Network, vol. 17, no. 1, pp. 4–12, 2006. View at Google Scholar · View at Scopus
  18. K. M. Barnes and J. L. Miner, “Role of resistin in insulin sensitivity in rodents and humans,” Current Protein and Peptide Science, vol. 10, no. 1, pp. 96–107, 2009. View at Publisher · View at Google Scholar · View at Scopus
  19. S. Bauer, M. Neumeier, J. Wanninger et al., “Systemic resistin is increased in type 2 diabetic patients treated with loop diuretics,” Journal of Diabetes and its Complications, vol. 25, no. 6, pp. 377–381, 2011. View at Publisher · View at Google Scholar · View at Scopus
  20. A. Stofkova, “Resistin and visfatin: regulators of insulin sensitivity, inflammation and immunity,” Endocrine Regulations, vol. 44, no. 1, pp. 25–36, 2010. View at Publisher · View at Google Scholar · View at Scopus
  21. S. W. Zarich, “Cardiovascular risk factors in the metabolic syndrome: impact of insulin resistance on lipids, hypertension, and the development of diabetes and cardiac events,” Reviews in Cardiovascular Medicine, vol. 6, no. 4, pp. 194–205, 2005. View at Google Scholar · View at Scopus
  22. B. G. Talayero and F. M. Sacks, “The role of triglycerides in atherosclerosis,” Current Cardiology Reports, vol. 13, pp. 544–552, 2011. View at Google Scholar
  23. A. Subauste and C. F. Burant, “DGAT: novel therapeutic target for obesity and type 2 diabetes mellitus,” Current Drug Targets Immune, Endocrine and Metabolic Disorders, vol. 3, no. 4, pp. 263–270, 2003. View at Google Scholar · View at Scopus
  24. A. M. Birch, L. K. Buckett, and A. V. Turnbull, “DGAT1 inhibitors as anti-obesity and anti-diabetic agents,” Current Opinion in Drug Discovery and Development, vol. 13, no. 4, pp. 489–496, 2010. View at Google Scholar · View at Scopus
  25. J. G. Duncan, “Mitochondrial dysfunction in diabetic cardiomyopathy,” Biochimica et Biophysica Acta, vol. 1813, no. 7, pp. 1351–1359, 2011. View at Publisher · View at Google Scholar · View at Scopus
  26. B. Turan, “Role of antioxidants in redox regulation of diabetic cardiovascular complications,” Current Pharmaceutical Biotechnology, vol. 11, no. 8, pp. 819–836, 2010. View at Google Scholar · View at Scopus
  27. A. K. Tiwari and J. M. Rao, “Diabetes mellitus and multiple therapeutic approaches of phytochemicals: present status and future prospects,” Current Science, vol. 83, no. 1, pp. 30–38, 2002. View at Google Scholar · View at Scopus
  28. A. Dembinska-Kiec, O. Mykkänen, B. Kiec-Wilk, and H. Mykkänen, “Antioxidant phytochemicals against type 2 diabetes,” British Journal of Nutrition, vol. 99, no. 1, pp. ES109–ES117, 2008. View at Publisher · View at Google Scholar · View at Scopus